Mosterín Höpping Ana, McElhaney Janet, Fonville Judith M, Powers Douglas C, Beyer Walter E P, Smith Derek J
Centre for Pathogen Evolution, University of Cambridge, Department of Zoology, Downing Street, Cambridge CB2 3EJ, UK; World Health Organization Collaborating Center for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.
Advanced Medical Research Institute of Canada, Sudbury, ON, Canada P3E 5J1.
Vaccine. 2016 Jan 20;34(4):540-546. doi: 10.1016/j.vaccine.2015.11.058. Epub 2015 Dec 5.
Numerous studies have explored whether the antibody response to influenza vaccination in elderly adults is as strong as it is in young adults. Results vary, but tend to indicate lower post-vaccination titers (antibody levels) in the elderly, supporting the concept of immunosenescence-the weakening of the immunological response related to age. Because the elderly in such studies typically have been vaccinated against influenza before enrollment, a confounding of effects occurs between age, and previous exposures, as a potential extrinsic reason for immunosenescence. We conducted a four-year study of serial annual immunizations with inactivated trivalent influenza vaccines in 136 young adults (16 to 39 years) and 122 elderly adults (62 to 92 years). Compared to data sets of previously published studies, which were designed to investigate the effect of age, this detailed longitudinal study with multiple vaccinations allowed us to also study the effect of prior vaccination history on the response to a vaccine. In response to the first vaccination, young adults produced higher post-vaccination titers, accounting for pre-vaccination titers, than elderly adults. However, upon subsequent vaccinations the difference in response to vaccination between the young and elderly age groups declined rapidly. Although age is an important factor when modeling the outcome of the first vaccination, this term lost its relevance with successive vaccinations. In fact, when we examined the data with the assumption that the elderly group had received (on average) as few as two vaccinations prior to our study, the difference due to age disappeared. Our analyses therefore show that the initial difference between the two age groups in their response to vaccination may not be uniquely explained by immunosenescence due to ageing of the immune system, but could equally be the result of the different pre-study vaccination and infection histories in the elderly.
众多研究探讨了老年人对流感疫苗的抗体反应是否与年轻人一样强烈。结果各不相同,但往往表明老年人接种疫苗后的滴度(抗体水平)较低,这支持了免疫衰老的概念,即与年龄相关的免疫反应减弱。由于此类研究中的老年人在入组前通常已接种过流感疫苗,年龄与既往接触史之间会产生效应混杂,这是免疫衰老的一个潜在外在原因。我们对136名年轻人(16至39岁)和122名老年人(62至92岁)进行了一项为期四年的研究,每年连续接种三价灭活流感疫苗。与之前旨在研究年龄影响的已发表研究数据集相比,这项详细的多次接种纵向研究使我们能够同时研究既往接种史对疫苗反应的影响。在首次接种疫苗后,年轻人接种疫苗后的滴度(考虑到接种前滴度)高于老年人。然而,在随后的接种中,年轻人和老年人年龄组之间对疫苗接种的反应差异迅速缩小。虽然在模拟首次接种疫苗的结果时年龄是一个重要因素,但随着连续接种,这个因素的相关性逐渐降低。事实上,当我们假设老年组在我们的研究之前平均只接种过两次疫苗来检查数据时,年龄导致的差异就消失了。因此,我们的分析表明,两个年龄组在疫苗接种反应上的初始差异可能并非唯一由免疫系统衰老导致的免疫衰老所解释,同样可能是老年人在研究前不同的接种和感染史的结果。